Hi-Tech Pharmacal Co. (HITK) Beats Q4 Views on Top and Bottom

Article Stock Quotes (1) Comments (0)

Hi-Tech Pharmacal Co, Inc. (NASDAQ: HITK) reported Q4 EPS of $1.08, $0.37 better than the analyst estimate of $0.71. Revenue for the quarter came in at $57.2 million versus the consensus estimate of $49.33 million.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
• China Cord Blood Corp. (CO) Tops Q4 EPS by 3c
• ChinaEdu Corp. (CEDU) Tops Q1 EPS by 2c

Create E-mail Alert Related Categories

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?